Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELUW) EPS (Weighted Average and Diluted) (2020 - 2025)

Historic EPS (Weighted Average and Diluted) for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to -$0.88.

  • Celularity's EPS (Weighted Average and Diluted) fell 2054.79% to -$0.88 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.33, marking a year-over-year decrease of 17295.08%. This contributed to the annual value of -$2.64 for FY2024, which is 7600.17% up from last year.
  • Per Celularity's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.88 for Q3 2025, which was down 2054.79% from -$1.02 recorded in Q2 2025.
  • Over the past 5 years, Celularity's EPS (Weighted Average and Diluted) peaked at $1.02 during Q4 2022, and registered a low of -$4.98 during Q3 2023.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.96, with a median of -$0.67 in 2024.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 11587.3% in 2021, then tumbled by 1670000.0% in 2023.
  • Over the past 5 years, Celularity's EPS (Weighted Average and Diluted) (Quarter) stood at $0.51 in 2021, then surged by 100.0% to $1.02 in 2022, then fell by 17.65% to $0.84 in 2023, then tumbled by 172.29% to -$0.61 in 2024, then crashed by 44.92% to -$0.88 in 2025.
  • Its last three reported values are -$0.88 in Q3 2025, -$1.02 for Q2 2025, and -$0.84 during Q1 2025.